The cerebrospinal fluid (CSF) pH influences brain interstitial pH and, therefore, brain function. We hypothesized that the choroid plexus epithelium (CPE) expresses the vacuolar H + -ATPase (V-ATPase) as an acid extrusion mechanism in the luminal membrane to counteract detrimental elevations in CSF pH. The expression of mRNA corresponding to several V-ATPase subunits was demonstrated by RT-PCR analysis of CPE cells (CPECs) isolated by fluorescence-activated cell sorting. Immunofluorescence and electron microscopy localized the V-ATPase primarily in intracellular vesicles with only a minor fraction in the luminal microvillus area. The vesicles did not translocate to the luminal membrane in two in vivo models of hypocapnia-induced alkalosis. The Na + -independent intracellular pH (pH i ) recovery from acidification was studied in freshly isolated clusters of CPECs. At extracellular pH (pH o ) 7.4, the cells failed to display significant concanamycin A-sensitive pH i recovery (i.e., V-ATPase activity). The recovery rate in the absence of Na + amounted to <10% of the pH i recovery rate observed in the presence of Na + . Recovery of pH i was faster at pH o 7.8 and was abolished at pH o 7.0. The concanamycin A-sensitive pH i recovery was stimulated by cAMP at pH 7.4 in vitro, but intraventricular infusion of the membrane-permeant cAMP analog 8-CPT-cAMP did not result in trafficking of the V-ATPase. In conclusion, we find evidence for the expression of a minor fraction of V-ATPase in the luminal membrane of CPECs. This fraction does not contribute to enhanced acid extrusion at high extracellular pH, but seems to be activated by cAMP in a trafficking-independent manner.
Introduction
Control of cerebrospinal fluid (CSF) pH is important, as it directly affects brain interstitial fluid (BIF) pH in the areas closest to the ventricle system (Okada et al. 1993) . High BIF pH is associated with several forms of seizures, and is in some instances the leading cause of this condition (Schuchmann et al. 2006) . The chemosensors of the brainstem may also be influenced by CSF acid-base status (Leusen 1954) , which could have detrimental effects on the control of respiration. It seems counterintuitive that CSF has a low content of protein buffers, and pH is, therefore, believed to be buffered almost exclusively by the open CO 2 /HCO 3 -system (Lee et al. 1969) . The fast equilibration of pCO 2 between blood and CSF (Johnson et al. 1983 ) could lead to abrupt and large fluctuations in CSF pH. In dogs, however, CSF pH recovery during hypocapnia-induced alkalosis is observed, which reaches significance after approximately 1 h and continues for the next 2-6 h (Kazemi et al. 1967) . Neither the origin of the acid/base equivalents for CSF pH recovery, nor the responsible molecular mechanisms have been studied systematically. We have previously described NHE1 as an acid extruder in the luminal (i.e., CSF-facing / apical) membrane of choroid plexus epithelium (CPECs) (Damkier et al. 2009) , and it could, therefore, be a mechanism for lowering CSF pH. However, the low abundance of NHE1 in CPECs leads us to speculate that other acid extruders might co-exist with NHE1 in the luminal membrane of CPE similar to what has previously been described for renal proximal tubule cells (Brown et al. 1988a) . Such mechanisms might include other NHE isoforms, the vacuolar H + -ATPase (V-ATPase), the H + /K + -ATPase, and the Slc4a11 gene product.
The V-ATPase is an obvious candidate for mediating regulated acid extrusion into the CSF. It is ubiquitously expressed in mammalian cells, where it acidifies several intracellular compartments, in particular the endosomal/ lysosomal system (for review see (Nelson and Harvey 1999) ). In specialized epithelial cells, such as kidney intercalated cells, the V-ATPase is involved in maintaining whole body acid/base balance and responds to a systemic acidosis by increasing acid extrusion (Bastani et al. 1991; Sabolic et al. 1997 ). In the pigmented cells of ocular ciliary epithelium, V-ATPase expression is mainly found in a subtype of cells and is thought to be involved in the formation of aqueous humor (Wax et al. 1997) . Similarly, in the olfactory epithelium, V-ATPase is expressed only in sustentacular and microvillar cells and is thought to regulate the pH of the mucus layer, thus being relevant in olfaction (Paunescu et al. 2008 (Paunescu et al. , 2012 . In the inner ear, the V-ATPase is important for maintaining high K + balance of the endolymph to enable hearing (Karet et al. 1999) . In the male reproductive tract, the V-ATPase participates in maintaining an acidic luminal pH to mature and store spermatozoa , and in osteoclasts, the V-ATPase in the ruffled membrane is vital for bone reabsorption (Baron et al. 1985) .
The V-ATPase is a multisubunit protein structurally similar to the mitochondrial F 1 F 0 ATP synthases (for review see (Forgac 2007) ). The V-ATPases generate a transmembrane proton gradient using the energy provided by ATP hydrolysis, and consist of an integral membrane protein V0 domain and a cytoplasmic V1 domain joined by a stalk domain. The protein complex is composed of at least 14 different subunits, many of which exist in multiple isoforms; the V1 consists of subunits A-H and the V0 consists of a, c, c'', d, e, and Ac45 (for review see (Nishi and Forgac 2002) ). The B1 isoform is expressed in high abundance in the plasma membrane of kidney and epididymis proton secreting cells (Nelson et al. 1992; Breton et al. 1996) . The B2 isoform is expressed in most cells in intracellular vesicles, such as lysosomes and endosomes and is usually not found in the plasma membrane (Puopolo et al. 1992) . The regulation of acid secretion by the V-ATPase in intercalated cells of the kidney collecting duct has been extensively studied. Trafficking of the V-ATPase is regulated by increased luminal , intracellular , and the HCO 3 --activated soluble adenylyl cyclase (sAC) with cAMP/PKA as downstream mediators (Paunescu et al. 2010; Gong et al. 2010) . Thus, the current study was undertaken to explore the hypothesis that the V-ATPase is expressed in the CPE and takes part in regulated acid extrusion into the luminal compartment, that is, the CSF.
Materials and Methods

Animals
In this study, we used, 8-12-week-old male C57BL/6 mice from Taconic (Denmark). All experiments were approved by the Danish Animal Experiments Inspectorate.
FACS of CPE cells
Mice were anesthetised by isoflurane inhalation and euthanized by cervical dislocation. The choroid plexi (CP) from all brain ventricles were removed and placed in HEPES-buffered saline (HBS) on ice (Table 1) . Pooled CP tissues from 6 to 8 mice were incubated in 50 lg/mL concanavalin A fluorescein (Vector Laboratories) in HBS for 10 min at 37°C, digested in 4 lg/mL dispase (Invitrogen) and 4 lg/mL collagenase B (Roche) in calcium-free HBS for 30 min at 37°C, and incubated in a 1:1 mixture of TrypLE Select Enzyme (Thermo-Fisher) and cell culture trypsin/EGTA (Thermo-Fisher) supplemented with 1 mg/mL DNase (Sigma) for 10 min at 37°C. The preparation was passed through a 50-lm filter, and propidium iodide was added before Fluorescence-activated cell sorting (FACS) for exclusion of dead cells. Cells were sorted into fluorescein-positive and fluorescein-negative samples by 4-way purity sorting on a FACS Aria III (BD Biosciences). The cells were sorted using a 70-lm nozzle, at 70 psi and 12-20 kHz. After FACS, the samples as well as control CP samples were spun for 1 min in a tabletop micro-centrifuge and the pellets were processed for total RNA isolation. Sample purity was validated by RT-PCR with primers targeting the epithelial marker Claudin-1 (Cldn1) and the endothelial marker Claudin-5 (Cldn5).
Reverse transcription -polymerase chain reaction (RT-PCR)
Mouse tissue was homogenized in TRI Reagent (Ambion), and total RNA was purified using the RiboPure ™ Kit (Ambion). RNA samples were DNase treated (Invitrogen), and cDNA synthesis was carried out, using the SuperScript II Reverse Transcriptase system (Invitrogen). RT-negative samples served as an internal control for the DNase treatment. PCR was performed on a DNA Engine DYAD Peltier Thermal Cycler (MJ Research) with initial denaturation at 95°C for 15 min, followed by 30-35 amplification cycles consisting of 30 sec of denaturation at 95°C, 30 sec of annealing at 58-60°C, and 30 sec of elongation at 72°C (see Table 2 for primer sequences and product sizes).
Antibodies
An affinity-purified V-ATPase antibody raised in rabbit against the 70-kDa A-subunit of the protein (HurtadoLorenzo et al. 2006 ) and a mouse monoclonal antibody raised against sAC (Zippin et al. 2003) were used in the study. , pH 7.4) with 0.1% vol/vol Tween), and incubated overnight at 5°C with primary antibody in PBS with 1% bovine serum albumin (BSA), and 2 mmol/L NaN 3 . After rinsing, the blots were incubated with horseradish peroxidase-conjugated anti-rabbit secondary antibody (Dako) and imaged (ImageQuant LAS4000, GE Healthcare).
Tissue preparation and immunostaining
Mice were anesthetized by isoflurane inhalation and perfusion fixed with 4% paraformaldehyde (PFA) in PBS for 4 min via the left cardiac ventricle. Brains were removed and immersion post fixed in 4% PFA in PBS for 1 h at 4°C. Tissues were rinsed in PBS and dehydrated in increasing concentrations of ethanol (70%, 96% and 99%, 2 h in each) before they were placed in xylene overnight. Tissues were infiltrated with paraffin for 1 h at 60°C. 2-lm sections were cut on a microtome (RM 2165; Leica Microsystems).
Tissue slides were deparaffinized in xylene, rehydrated in decreasing concentrations of ethanol (99%, 96%, and 70%), and rinsed in PBS. For antigen retrieval, slides were treated with 1% (w/v) SDS in PBS for 4 min and washed in PBS. Sections were blocked with 1% (w/v) bovine serum albumin in PBS containing 0.02% sodium azide for 20 min and incubated with primary antibody for 90 min at room temperature. Slides were washed in PBS, incubated with secondary antibody for 60 min at room temperature, washed again and mounted with coverslips using Vectashield mounting medium (Vector Laboratories Inc.) containing DAPI, or incubated with Topro3 (Invitrogen) nuclear stain before mounting with glycergel antifade (Dako). An 80i epifluorescence microscope (Nikon Instruments) equipped with an Orca 100 CCD camera (Hamamatsu) or a DM IRE2 inverted confocal microscope (Leica Microsystems) was used to acquire the digital images.
Analysis of cellular V-ATPase distribution
Quantification of V-ATPase distribution was performed by line scanning (ImageJ software, National Institutes of Health) across cells with a visible nucleus. The line was perpendicular to the basement membrane and expanded to a band with a width of 21 pixels and placed in the mid-nuclear plane of each cell containing a nucleus in all images (2-8 images per mouse). The number of bins (measurement points) was compressed to 50 (or 40, in Fig. 5 ) for each cell and the average staining intensity for each bin was calculated for each of the ten mice, where bin #1 represents the basal end of the cells. At the luminal end, the last 5 bins most likely represent the brush border. To correct for background staining, the lowest staining intensity from each mouse was subtracted from each of the other bins from the same mouse. After this, the average staining intensity for each of the 50 (or 40) bins was calculated for all nucleated cells for each mouse and averaged for every group of 5 mice (hyperthermia-treated mice and control mice).
Immunogold electron microscopy
The choroid plexus that was fixed with 4% paraformaldehyde in PBS (0.9% NaCl in 10 mmol/L phosphate buffer, pH 7.4) was dehydrated through a graded ethanol series to 100% ethanol and subsequently infiltrated, embedded, and polymerized in LR White resin (EMS) at 50°C as previously described (Paunescu et al. 2010) . Thin choroid plexus sections were cut to approximately 70-nm sections on an EM UC7 ultra-microtome (Leica Microsystems) and collected onto formvar-coated grids. The grids were floated on drops of primary rabbit anti-V-ATPase A subunit antibody diluted 1:50 in antibody diluent (Dako) for 2 h at room temperature, rinsed on drops of PBS, and floated on drops of goat anti-rabbit IgG antibody coupled to 15-nm gold particles diluted 1:15 in antibody diluent for 1 h at room temperature. The grids were rinsed, poststained on drops of 2% uranyl acetate for 5 min, rinsed, and dried. The choroid plexus sections were examined in a JEM-1011 transmission electron microscope (JEOL) at 80 kV. Images were acquired using an AMT XR60 digital imaging system (Advanced Microscopy Techniques).
Intracellular pH (pH i ) measurements
Experiments were conducted as described previously (Damkier et al. 2009 ). Isolated CP tissues were digested into single-layered cell clusters by 4 lg/mL dispase (Invitrogen) and 4 lg/mL collagenase B (Roche) in calciumfree HBS (Table 1) prepulse for 3-5 min (NH 4 Cl HBS, Table 1 ) followed by Na + -free HBS (0Na + HBS, Table 1 ). Each experiment was concluded with a one-point calibration in pH 7.0, high K + HBS (Table 1) containing 10 lmol/L nigericin. Till Vision software (Till Photonics) was used to control monochromator wavelength alternating between 490 nm and 440 nm, exposure time (20 msec), frequency (1 Hz), and binning (to 512 9 512 pixel images). The light emission at 510-535 nm was recorded by a 12-bit cooled monochrome CCD camera (QImaging, Retiga EXi) and data were collected from user-defined regions of interest (ROIs) of individual cells after background subtraction. The fluorescence ratio (490/440 nm) was calibrated to pH by clamping pH i stepwise from pH 8-6 in high-K + HBS with 10 lmol/L nigericin (Boyarsky et al. 1988 ). The rate of pH i recovery (dpH i /dt) was determined as the pH i change in 30 sec after peak minimum pH i .
Measurement of membrane potential (V m ) in isolated CPE cells
Isolated clusters of CPECs were plated in Cell-Tak (BD Biosciences) coated culture dishes (Falcon, Becton Dickson) containing HBS. Isolated cells and small pieces of epithelia were allowed to adhere to the chamber bottom for 15 min prior to Vm recording (Kotera and Brown 1994) . All recordings were made at room temperature with borosilicate glass patch pipettes (Harvard Apparatus) with resistances in the range of 2-5 MΩ. Recordings were made with an Axopatch 200B amplifier (Axon Instruments Inc., CA) by switching from the voltage-clamp to current-clamp mode. First, a whole-cell configuration was established in voltage-clamp mode (seal resistance >1 GΩ; access resistance 5-10 MΩ) and then immediately switched to the current-clamp mode to detect Vm. Vm detected immediately after establishing the whole-cell configuration (within no more than 1 min) was recorded for further analyses. Pipette solution in these experiments contained (in mM): 140 K + , 4 Na + , 2 Mg 2+ , 120 aspartate, 24 Cl -, 2 ATP 2-, 0.5 EGTA, 5 HEPES and adjusted to pH = 7.4, while HBS was used as bath solution.
Respiratory alkalosis (hypocapnia) by hyperthermia and hypoxia
For hyperthermia, a heating lamp was used to increase the temperature of a container to 42°C. The mice were placed in the container individually for 5-7 min, thereby inducing hyperventilation and causing wash out of CO 2 before isoflurane anesthesia was induced. Controls were placed in the chamber for the same amount of time but at room temperature. For hypoxia, the mice were placed inside a chamber containing a gas mixture of 12% O 2 in 88% N 2 for 5 min before induction of isoflurane anesthesia in the same gas mixture. The control mice inhaled normal air. For both experiments, blood samples were drawn from the right atrium of the heart and the mice were perfusion fixed with 4% PFA in PBS via the left ventricle. Blood was analyzed on an ABL80 Flex blood gas analyzer (Radiometer).
Stereotactic injection of cAMP into brain ventricles of mice
Mice were anesthetized by a bolus intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg) followed by continuous injections of smaller doses of anesthesia as needed. Each mouse was placed in stereotactic equipment (David Kopf Instruments) and a Hamilton syringe was inserted 2.5 mm through the skull into the lateral ventricles at coordinates 0.8 mm lateral, and 0.1 mm caudal to bregma. A volume of 5.5 lL 10 mmol/ L 8-CPT-cAMP (Sigma-Aldrich) or vehicle (artificial CSF/ aCSF, Alzet) was slowly injected (0.5 lL/min). After 30 min, the mouse was perfusion fixed and the brain was subjected to immunohistochemistry.
Statistics
Mean values for pH i recovery rate were compared by nonparametric ANOVA with Dunnet posttest, as the data did not pass the normality test. V-ATPase-staining intensities and blood gas values were analyzed by a twotailed t-test. For all analyses, P < 0.05 was considered significant.
Results
The V-ATPase is expressed mainly in intracellular vesicles of CPECs
Luminal membrane labeling with fluorescent lectin, cell separation (Fig. 1A) , and FACS yielded 99.8-100% pure fluorescein-positive CPECs (Fig. 1B) . RT-PCR on cDNA from FACS isolated CPECs for the epithelial marker claudin-1 and the endothelial marker claudin-5 (Fig. 1B) , as well as collagen I (fibroblastic marker, not shown) validated that these samples were pure suspensions of CPE cells. RT-PCR demonstrated expression of V-ATPase subunits A and B2, but not B1, in the CPECs (Fig. 2A) . Additionally, we detected C1, C2, and d1 subunits in nonsorted CPEC samples (Fig. 2B) . Immunoblotting produced a V-ATPase A-immunoreactive band of a size corresponding to the calculated MW of 68 kDa in both CP and kidney samples (Fig. 2C ). Immunohistochemical analysis localized the V-ATPase A subunit mainly to intracellular compartments in the CPECs (Fig. 2D) . A similar staining pattern was seen using a B2 subunit-specific antibody (not shown). Immunogold electron microscopy supported the predominant intracellular vesicular localization (Fig. 2E) . Sparse labeling was observed in the microvilli of the CPECs. Thus, multiple subunits of the V-ATPase are expressed in CPECs and mainly observed in intracellular vesicles. + prepulse and the Na + -independent pH i recovery was estimated from the point of maximal acidification. Concanamycin A was applied to determine the contribution of V-ATPase activity to the Na + -independent pH i recovery. No significant effect of concanamycin A on pH i recovery was found compared to control conditions at pH o 7.4 (n.s., n = 7 and 8 respectively, Fig. 3A) . The initial pH i following acidification was 5.97 AE 0.14 in the control experiments and 5.94 AE 0.18 in the concanamycin A experiments. Figure 3B shows that pH i recovery after acidification was almost absent at pH o 7.0, while it was more prominent at pH o 7.4 and even more so at pH o 7.8. The dpH i /dt was not significantly different from zero at pH o 7.0 (n.s., n = 4), while dpH i / dt increased with increasing pH o (P = 0.0063 between pH o 7.0 and 7.8, n = 4 and 7, respectively). The initial pH i among the three pH o levels was 6.29 AE 0.31 at pH o 7.0, 5.97 AE 0.14 at pH o 7.4, and 6.34 AE 0.27 at pH o 7.8 (n.s.). As illustrated in Figure 3C , concanamycin A seemed to induce a reduction of the pH i recovery at pH o 7.8, although the change was not statistically significant compared to control (n.s., n = 6 and 7, respectively). The initial pH i was 6.34 AE 0.27 in the control experiments and 6.32 AE 0.19 in the concanamycin A experiments (n.s.). Thus, the V-ATPase does not seem to contribute significantly to pH i recovery in acidified CPE cells. (H + ), is À42 mV at pH o 7.0, À67 mV at pH o 7.4, and À92 mV at pH o 7.8.
The Na + -independent pH i recovery is modest compared to the NHE activity in CPECs
To compare the relative contribution of NHE activity (Na + -dependent recovery) and V-ATPase/leak-mediated H + translocation (Na + -independent recovery), the rate of pH i recovery was compared directly before and after the addition of Na + in acidified cells in the same experiment. The dpH i /dt in Na + -free HBS amounted to 2.63 AE 1.02% of dpH i /dt in Na + containing HBS at pH i 6.45 AE 0.14 (P < 0.0001, n = 6, Fig. 4A and B) , while dpH i /dt in Na + -free HBS was 8.78 AE 2.02% of dpH i /dt in Na + containing HBS at pH i 6.68 AE 0.04 (P < 0.0001, n = 4). This indicates that NHE activity plays the dominant role in HCO 3 -independent acid extrusion by the CPE at low pH i . In other tissues, regulated V-ATPase activity is dependent on the presence of CO 2 /HCO 3 - (Pastor-Soler et al. 2003) . In the isolated choroid plexus cells, however, the presence of CO 2 / HCO 3 -in the perfusate following acidification did not significantly increase the concanamycin-sensitive, Na + -independent pH i recovery (n = 3, ANOVA P = 0.95, Fig. 4C ). It seems that the Na + -independent pH i recovery is modest compared to NHE activity, especially at low pH i values, and is not augmented by the presence of CO 2 /HCO 3 -.
Hypocapnia does not lead to redistribution of the V-ATPase to the plasma membrane in CPECs
In kidney and epididymis, the V-ATPase is known to react to extra-or intracellular pH changes by accumulation in the luminal membrane via activation of sAC (Pastor-Soler et al. 2003) . The possible luminal V-ATPase membrane accumulation in CPE during alkalization was investigated by decreasing the arterial CO 2 partial pressure (p a CO 2 ) in two ways: By increasing the ambient temperature, thereby causing hyperventilation and CO 2 washout, and by lowering pO 2 in the ambient air, which similarly leads to hyperventilation. Blood gas analysis confirmed a significant decrease in plasma pCO 2 and a significant increase in plasma pH after 5 minutes of increased ambient temperature. The p a CO 2 was 4.92 AE 0.25 kPa after increased ambient temperature and 5.98 AE 0.12 kPa under control conditions (P = 0.0143, n = 13 and 10, respectively), while the pH was 7.41 AE 0.01 after increased ambient temperature and 7.34 AE 0.01 under control conditions (P = 0.0017). Immunohistochemical analysis of brain tissue sections from mice subjected to increased ambient temperature showed a statistically significant redistribution of the V-ATPase toward both the luminal and the basolateral plasma membrane domains of the choroid plexus cells (Fig. 5A-C) . Lowering of pO 2 also produced a significant decrease in plasma pCO 2 and a significant increase in plasma pH. The pCO 2 was 5.02 AE 0.31 kPa after lowering of pO 2 and 6.65 AE 0.10 under control conditions (P = 0.0005, n = 6), while the pH was 7.37 AE 0.02 after lowering of pO 2 and 7.30 AE 0.01 under control conditions (P = 0.0107).
Except for very few bins across the cells, immunohistochemistry revealed statistically insignificant changes in VATPase distribution in the CPE upon lowering pO 2 (Fig. 5D) . Importantly, both protocols apparently failed to induce luminal plasma membrane accumulation of the V-ATPase in CPE cells.
Exposure to cAMP increases V-ATPase activity in CPECs independently of vesicle trafficking
In agreement with the lack of membrane accumulation of the V-ATPase during hypocapnia, mRNA encoding sAC was absent from FACS isolated CPE cells (Fig. 6A) , and the CPE failed to display anti-sAC immunolabeling (Fig. 6B) . In kidney proximal tubules and intercalated cells, the V-ATPase is known to traffic to the apical membrane upon direct stimulation by cAMP, and we therefore speculated that a similar mechanism might operate in CPE cells independently of sAC expression. In isolated clusters of CPE cells, 30 min preincubation in 1 mM 8-CPT-cAMP indeed doubled the rate of Na + -independent pH i recovery (n = 7, ANOVA P = 0.0037, Fig. 6B and C) . The increase was completely abolished by concanamycin A, indicating that the increased pH i recovery was caused by V-ATPase activity. Nevertheless, immunohistochemical analysis of cellular V-ATPase distribution showed that in vivo cAMP-injection did not cause statistically significant redistribution of the V-ATPase in the choroid plexus (n = 4, n.s., Fig. 6D , E and F). This indicates a trafficking-independent activation of the V-ATPase by cAMP.
Discussion
In this study, we investigate the expression, activity, and regulation of the V-ATPase in the choroid plexus epithelium. We show that the choroid plexus expresses the B2 but not the B1 subunit isoform of the V-ATPase. The V-ATPase in CPE is mainly found in intracellular compartments both under normal conditions and during alkalinization of the cerebrospinal fluid. Furthermore, the concanamycin A-sensitive Na + -independent acid extrusion (i.e., V-ATPase activity) is statistically insignificant in acidified CPE and numerically negligible compared to Na + -dependent acid extrusion (NHE activity) both in the presence and absence of CO 2 /HCO 3 -. The V-ATPase does not redistribute toward the luminal membrane upon hypocapnia or direct application of cAMP to the brain ventricles. However, membrane-permeant cAMP increases V-ATPase activity in the CPE ex vivo.
Research activity in the 1950-1970s revealed the basic mechanisms protecting CSF from major disturbances in acid-base balance, and the possible involvement of acid/ base secretion by the CPE cells in this process (Kazemi and Choma 1977; Vogh and Maren 1975; Husted and Reed 1977) . Few studies have been carried out to uncover the molecular mechanisms involved in this regulation. CSF contains very little protein compared to plasma (Boron and Boulpaep 2012) and is, therefore, dependent on the actions of other buffers and/or an appropriate supply of acid /base equivalents to maintain pH. Changes in arterial pCO 2 are directly transferred to the CSF (Siesjoe and Thompson 1965). The resultant CSF pH change, however, is not as large as would be expected by a nonprotein buffered fluid (Johnson et al. 1983 ). CSF pH is buffered by the CO 2 /HCO 3 -buffering system, and pH regulation in response to alkaline challenges during hypocapnia is dependent on either removal of HCO 3 -or transport of H + into the CSF. The choroid plexus is situated in a favorable position for regulating CSF pH and is known to express several integral plasma membrane proteins, which could participate in acid/base transport (Damkier et al. 2013) . We previously demonstrated the expression of the Na + / H + exchanger NHE1 (Slc9a1) in the luminal CPE membrane (Damkier et al. 2009 ). This protein transports Na + from the CSF into the cell in exchange for H + , indicating a role for this transporter in response to an alkaline CSF. In the current study, we find expression of the A, B2, C1 and d1 subunits of the V-ATPase in fractions of CPE highly enriched in CP epithelial cells to avoid contamination from the endothelial cells that express many of the same proteins. The protein expression of V-ATPase subunits in the CPE cells was confirmed by immunoblotting and immunohistochemical staining. This is in agreement with a previous study by Mooradian and Bastani (1993) . We mainly observed the immunoreactive proteins in cytosolic compartments, which resemble vesicles by electron microscopy. Nevertheless, the minor fraction of V-ATPase immunoreactivity observed in the microvilli of the CPE cells is supported by mass spectrometry analysis of luminal surface biotinylated CPE cells, which detected unique peptides for the V-ATPase subunits a1, a2, A, B2, C1, D, d1, E1, F, G1, G2, H, and the accessory protein S1 (unpublished data).
In several cell types, intracellular V-ATPase is known to traffic to the plasma membrane to acidify the extracellular fluid (Gluck et al. 1982) . This phenomenon has been observed in both renal intercalated cells (Brown et al. 1988b) and in clear cells of the epididymis (Breton et al. 2000) . Expression of the B1 subunit has been associated with trafficking to the plasma membrane, as it has been observed in the kidney and epididymis, whereas the ubiquitously expressed B2 subunit is mostly associated with V-ATPase localization in the lysosomal system. In osteoclasts, however, the B2 subunit is highly expressed in the ruffled membrane, enabling bone matrix degradation (Lee et al. 1996) . Furthermore, the B2 subunit has also been detected in the apical membranes of cells in renal proximal tubules and intercalated cells of the collecting duct, suggesting a role in proton secretion and maintenance of acid-base homeostasis as well (Paunescu et al. 2004 (Paunescu et al. , 2007 . Thus, the lack of B1 expression in CPE is not indicative of an inability of regulated membrane trafficking of the V-ATPase complex.
Concanamycin-sensitive V-ATPase activity was not detectable in isolated CPE cells at physiological pH o . Therefore, to test whether V-ATPase activity was sensitive to extracellular pH, freshly isolated CP cells were acidified and exposed to varying pH o during the pH i recovery period. We observed a slow Na + -independent pH i recovery that seemed to increase as the pH o increased. This recovery might be attributed to either V-ATPase activity or to a passive transport of H + out of the cells. However, even after intracellular acidification and pH i recovery at very high extracellular pH (pH 7.8), we find no significant concanamycin A-sensitive acid extrusion in the CPE cells. This seems to exclude the involvement of V-ATPase + efflux than by V-ATPase activity. This efflux could occur through specific membrane proteins, such as yet undescribed H + /OH -transporters, channels, or through leak pathways in the lipid bilayer. Furthermore, the Na + -independent acid extrusion is negligible compared to the acid extrusion in the presence of Na + (NHE1 activity) in CPE cells, suggesting that NHE activity is more likely to be involved in potent acid extrusion by the CPE cells than the probably passive H + efflux. To investigate whether trafficking of the V-ATPase in the CPE can be induced by an external stimulus such as an increased CSF pH, we applied two animal models, in which we alkalized the CSF by inducing respiratory alkalosis. Hypocapnia induced by hyperthermia and by hypoxia both caused a decrease in arterial pCO 2 (p a CO 2 ). It has previously been shown that the pCO 2 and pH of CSF rapidly follows changes in p a CO 2 , and we confirmed the rise in CSF pH by hypoxia in vivo in the murine system (not shown). In the hypocapnia by hyperthermia model, we find that the V-ATPase localizes nearer to the luminal membrane compared to nontreated mice but still in subluminal compartments and apparently not in the membrane. In the hypocapnia by hypoxia model, no significant re-localization took place. This indicates that the intracellular redistribution of V-ATPase during hyperthermia could be a temperature effect rather than a result of the hypocapnia. In other epithelia, alkalization is sensed by sAC, and the resulting cAMP signal activates PKAdependent accumulation of V-ATPase in the plasma membrane (Gong et al. 2010 ). However, we do not find evidence for sAC expression in mouse CPE. Thus, the mouse CPE does not seem to contain the HCO 3 --sensitive system for V-ATPase trafficking.
The lack of alkalization-induced plasma membrane V-ATPase accumulation did not exclude a direct stimulatory effect of cAMP on V-ATPase trafficking or function, as observed in epididymis and renal intercalated cells (Paunescu et al. 2010; Pastor-Soler et al. 2003) . Stimulating isolated CPE cells with cAMP induced a concanamycinsensitive, Na + -insensitive pH i recovery, that is, V-ATPase activity. Surprisingly, the apparent induction of V-ATPase activity ex vivo was not mirrored by V-ATPase re-distribution in CPE, when cAMP was injected into the brain ventricles in vivo. One might speculate that cAMP can either directly stimulate the fraction of V-ATPases already residing in the plasma membrane, or induce intracellular acidification of BCECF-negative vesicles sufficiently large to reduce cytosolic pH. We have not obtained an animal experiment license to inject concanamycin A into the mouse brain ventricles and are, therefore, prevented from determining the putative effect of cAMP-induced V-ATPase activity on CSF pH in vivo. Thus, further studies are necessary to investigate both the short-term and especially longer-term effects of cAMP on acid/base transporters including the V-ATPase in the choroid plexus. At present, we cannot rule out a possible role for the V-ATPase in pH regulation in the CP in longer-term acid/base disturbances.
In conclusion, the V-ATPase is expressed mainly in intracellular compartments of CPE cells with minor expression in the luminal plasma membrane. Neither a hypocapnia-induced increase in CSF pH nor stimulation with cAMP causes accumulation of the V-ATPase in the luminal plasma membrane of CPE cells. Plasma membrane V-ATPase activity is negligible both under normal conditions and at high extracellular pH. However, direct application of the membrane-permeant cAMP analog 8-CPT-cAMP to CPE cells stimulates V-ATPase-mediated pH i recovery in a trafficking-independent manner. The transient nature and the magnitude of the cAMP-stimulated V-ATPase activity make this mechanism unlikely to mediate physiologically significant contributions to shortterm acidification of the CSF.
